67 related articles for article (PubMed ID: 36801946)
1. Vaccination Ameliorates Cellular Inflammatory Responses in SARS-CoV-2 Breakthrough Infections.
Huapaya JA; Higgins J; Kanth S; Demirkale CY; Gairhe S; Aboye EA; Regenold D; Sahagun SJ; Pastor G; Swaim D; Dewar R; Rehman T; Highbarger HC; Lallemand P; Laverdure S; Adelsberger J; Rupert A; Li W; Krack J; Teferi G; Kuruppu J; Strich JR; Davey R; Childs R; Chertow D; Kovacs JA; Barnett C; Torabi-Parizi P; Suffredini AF;
J Infect Dis; 2023 Jun; 228(1):46-58. PubMed ID: 36801946
[TBL] [Abstract][Full Text] [Related]
2. Intertwined Dysregulation of Ribosomal Proteins and Immune Response Delineates SARS-CoV-2 Vaccination Breakthroughs.
Maurya R; Shamim U; Mishra P; Swaminathan A; Raina A; Tarai B; Budhiraja S; Pandey R
Microbiol Spectr; 2023 Jun; 11(3):e0429222. PubMed ID: 37022180
[TBL] [Abstract][Full Text] [Related]
3. Breakthrough SARS-CoV-2 infection outcomes in vaccinated patients with chronic liver disease and cirrhosis: A National COVID Cohort Collaborative study.
Ge J; Digitale JC; Pletcher MJ; Lai JC;
Hepatology; 2023 Mar; 77(3):834-850. PubMed ID: 36799617
[TBL] [Abstract][Full Text] [Related]
4. A prognostic model for SARS-CoV-2 breakthrough infection: Analyzing a prospective cellular immunity cohort.
Yang M; Meng Y; Hao W; Zhang J; Liu J; Wu L; Lin B; Liu Y; Zhang Y; Yu X; Wang X; Gong Y; Ge L; Fan Y; Xie C; Xu Y; Chang Q; Zhang Y; Qin X
Int Immunopharmacol; 2024 Apr; 131():111829. PubMed ID: 38489974
[TBL] [Abstract][Full Text] [Related]
5. Preoperative SARS-CoV-2 infection increases risk of early postoperative cardiovascular complications following noncardiac surgery.
SenthilKumar G; Verhagen NB; Sheriff SA; Yang X; Figueroa Castro CE; Szabo A; Taylor BW; Wainaina N; Lauer K; Gould JC; Kothari AN;
Am J Physiol Heart Circ Physiol; 2023 Jun; 324(6):H721-H731. PubMed ID: 36930659
[TBL] [Abstract][Full Text] [Related]
6. Prior vaccination promotes early activation of memory T cells and enhances immune responses during SARS-CoV-2 breakthrough infection.
Painter MM; Johnston TS; Lundgreen KA; Santos JJS; Qin JS; Goel RR; Apostolidis SA; Mathew D; Fulmer B; Williams JC; McKeague ML; Pattekar A; Goode A; Nasta S; Baxter AE; Giles JR; Skelly AN; Felley LE; McLaughlin M; Weaver J; ; Kuthuru O; Dougherty J; Adamski S; Long S; Kee M; Clendenin C; da Silva Antunes R; Grifoni A; Weiskopf D; Sette A; Huang AC; Rader DJ; Hensley SE; Bates P; Greenplate AR; Wherry EJ
Nat Immunol; 2023 Oct; 24(10):1711-1724. PubMed ID: 37735592
[TBL] [Abstract][Full Text] [Related]
7. Neurological disorders throughout acute SARS-CoV2 infection: A comparative study between vaccinated and non-vaccinated patients.
Cristillo V; Pilotto A; Piccinelli SC; Libri I; Locatelli M; Giunta M; Mazzoleni V; Pezzini D; Arici D; Gipponi S; di Cola FS; Cottini E; Gamba M; Magoni M; Padovani A
J Neurol Sci; 2024 Feb; 457():122898. PubMed ID: 38281402
[TBL] [Abstract][Full Text] [Related]
8. Leukocyte Activation Patterns in Hospitalized Children: Comparing SARS-CoV-2, Bacterial Infections, and Inflammatory Pathologies.
Domitien Payet L; Bedin AS; Desselas É; Marie-Jeanne C; Mollevi C; Malergue F; Bourgoin P; Van de Perre P; Tuaillon É; Jeziorski É
J Leukoc Biol; 2024 Apr; ():. PubMed ID: 38648502
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal Analysis of SARS-CoV-2 Vaccine Breakthrough Infections Reveals Limited Infectious Virus Shedding and Restricted Tissue Distribution.
Ke R; Martinez PP; Smith RL; Gibson LL; Achenbach CJ; McFall S; Qi C; Jacob J; Dembele E; Bundy C; Simons LM; Ozer EA; Hultquist JF; Lorenzo-Redondo R; Opdycke AK; Hawkins C; Murphy RL; Mirza A; Conte M; Gallagher N; Luo CH; Jarrett J; Conte A; Zhou R; Farjo M; Rendon G; Fields CJ; Wang L; Fredrickson R; Baughman ME; Chiu KK; Choi H; Scardina KR; Owens AN; Broach J; Barton B; Lazar P; Robinson ML; Mostafa HH; Manabe YC; Pekosz A; McManus DD; Brooke CB
Open Forum Infect Dis; 2022 Jul; 9(7):ofac192. PubMed ID: 35791353
[TBL] [Abstract][Full Text] [Related]
10. Transcriptionally active nasopharyngeal commensals and opportunistic microbial dynamics define mild symptoms in the COVID 19 vaccination breakthroughs.
Devi P; Kumari P; Yadav A; Tarai B; Budhiraja S; Shamim U; Pandey R
PLoS Pathog; 2023 Feb; 19(2):e1011160. PubMed ID: 36800345
[TBL] [Abstract][Full Text] [Related]
11. Breakthrough infections after COVID-19 vaccinations do not elicit platelet hyperactivation and are associated with high platelet-lymphocyte and low platelet-neutrophil aggregates.
Maiorca F; Lombardi L; Marrapodi R; Pallucci D; Sabetta A; Zingaropoli MA; Perri V; Flego D; Romiti GF; Corica B; Miglionico M; Russo G; Pasculli P; Ciardi MR; Mastroianni CM; Ruberto F; Pugliese F; Pulcinelli F; Raparelli V; Cangemi R; Visentini M; Basili S; Stefanini L
Res Pract Thromb Haemost; 2023 Nov; 7(8):102262. PubMed ID: 38193050
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal home self-collection of capillary blood using
Lim FY; Kim SY; Kulkarni KN; Blazevic RL; Kimball LE; Lea HG; Haack AJ; Gower MS; Stevens-Ayers T; Starita LM; Boeckh M; Schiffer JT; Hyrien O; Theberge AB; Waghmare A
medRxiv; 2023 Jan; ():. PubMed ID: 37034678
[TBL] [Abstract][Full Text] [Related]
13. Letter to the Editor: What is the actual role of decompensated cirrhosis in the breakthrough SARS-CoV-2 infection?
Hu Y; Li Z; He W; Wang X; Cheng X
Hepatology; 2023 Oct; 78(4):E76-E77. PubMed ID: 37459555
[No Abstract] [Full Text] [Related]
14. Feasibility of Measuring Physiological Responses to Breakthrough Infections and COVID-19 Vaccine Using a Wearable Ring Sensor.
Pho GN; Thigpen N; Patel S; Tily H
Digit Biomark; 2023; 7(1):1-6. PubMed ID: 37008738
[TBL] [Abstract][Full Text] [Related]
15. Antibody Response to Breakthrough SARS-CoV-2 Infection in "Booster" Vaccinated Patients with Multiple Myeloma According to B/T/NK Lymphocyte Absolute Counts and anti-CD38 Treatments.
Sgherza N; Mestice A; Larocca AMV; Musto P
Mediterr J Hematol Infect Dis; 2024; 16(1):e2024022. PubMed ID: 38468827
[No Abstract] [Full Text] [Related]
16. Breakthrough SARS-CoV-2 infections, morbidity, and seroreactivity following initial COVID-19 vaccination series and additional dose in patients with SLE in New York City.
Saxena A; Engel AJ; Banbury B; Hasan G; Fraser N; Zaminski D; Masson M; Haberman RH; Scher JU; Ho G; Law J; Rackoff P; Tseng CE; Belmont HM; Clancy RM; Buyon JP; Izmirly PM
Lancet Rheumatol; 2022 Sep; 4(9):e582-e585. PubMed ID: 35856060
[No Abstract] [Full Text] [Related]
17. RE: Incidence of SARS-CoV-2 Breakthrough Infections After Vaccination in Adults: A Population-Based Survey Through 1 March 2023.
DeSantis SM; Yaseen A; Hao T; León-Novelo L; Talebi Y; Valerio-Shewmaker MA; Pinzon Gomez CL; Messiah SE; Kohl HW; Kelder SH; Ross JA; Padilla LN; Silberman M; Wylie S; Lakey D; Shuford JA; Pont SJ; Boerwinkle E; Swartz MD
Open Forum Infect Dis; 2023 Dec; 10(12):ofad564. PubMed ID: 38099238
[No Abstract] [Full Text] [Related]
18. SARS-CoV-2 clearance after breakthrough infection correlates with fit and happy cells.
Veldhoen M; Bertoletti A
Immunol Cell Biol; 2023 Aug; 101(7):672. PubMed ID: 37401266
[No Abstract] [Full Text] [Related]
19. Posterior Pharyngeal Follicles in a Woman with Breakthrough SARS-CoV-2 Infection.
Takahashi H
Am J Trop Med Hyg; 2022 Mar; 106(5):1295. PubMed ID: 35292599
[No Abstract] [Full Text] [Related]
20. The musculoskeletal manifestations of SARS-CoV-2 infections/vaccinations are more diverse than expected.
Finsterer J
Skeletal Radiol; 2024 Feb; ():. PubMed ID: 38308722
[No Abstract] [Full Text] [Related]
[Next] [New Search]
